FEIBA
STN: BL 101447
Proper Name: Anti-Inhibitor Coagulant Complex
Tradename: FEIBA
Manufacturer: Takeda Pharmaceuticals USA, Inc.
Indication:
Indicated for use in hemophilia A and B patients with inhibitors for:
- Control and prevention of bleeding episodes.
- Perioperative management.
- Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.